Sharon Nachman, MD

Dr. Nachman is a board-certified Pediatric Infectious Disease specialist with over 3 decades of experience treating infants children and adolescents. Research funded by NIH since 1992, she is currently the Principal Investigator and Chair of the NIH-funded International Maternal Pediatric and Adolescent Clinical Trials Network (www.IMPAACTnetwork.org). She has developed and directed over 30 clinical trials that have changed the way we treat HIV and TB as well as used vaccines and novel therapeutics in children.  Recognized by both Newsday and New York Magazine as one of NY's top doctors in Pediatric Infectious Disease, she works closely with the communities of Long Island to treat illnesses common to Long Island such as resistant bacterial and tick-borne infections. 

Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults. Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2016 Mar

Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial. Beneri CA, Aaron L, Kim S, Jean-Philippe P, Madhi S, Violari A, Cotton MF, Mitchell C, Nachman S; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2016 Jan

Population pharmacokinetic analysis of raltegravir pediatric formulations in HIV-infected children 4 weeks to 18 years of age. Rizk ML, Du L, Bennetto-Hood C, Wenning L, Teppler H, Homony B, Graham B, Fry C, Nachman S, Wiznia A, Worrell C, Smith B, Acosta EP; Journal of clinical pharmacology, 2015 Jul

A double-blind, randomised, placebo-controlled, dose-finding trial of the novel tuberculosis vaccine AERAS-402, an adenovirus-vectored fusion protein, in healthy, BCG-vaccinated infants. Tameris M, Hokey DA, Nduba V, Sacarlal J, Laher F, Kiringa G, Gondo K, Lazarus EM, Gray GE, Nachman S, Mahomed H, Downing K, Abel B, Scriba TJ, McClain JB, Pau MG, Hendriks J, Dheenadhayalan V, Ishmukhamedov S, Luabeya AK, Geldenhuys H, Shepherd B, Blatner G, Cardenas V, Walker R, Hanekom WA, Sadoff J, Douoguih M, Barker L, Hatherill M; Vaccine, 2015 Jun 9

Towards early inclusion of children in tuberculosis drugs trials: a consensus statement. Nachman S, Ahmed A, Amanullah F, Becerra MC, Botgros R, Brigden G, Browning R, Gardiner E, Hafner R, Hesseling A, How C, Jean-Philippe P, Lessem E, Makhene M, Mbelle N, Marais B, McIlleron H, McNeeley DF, Mendel C, Murray S, Navarro E, Anyalechi EG, Porcalla AR, Powell C, Powell M, Rigaud M, Rouzier V, Samson P, Schaaf HS, Shah S, Starke J, Swaminathan S, Wobudeya E, Worrell C; The Lancet. Infectious diseases, 2015 Jun

Psychiatric symptoms and antiretroviral nonadherence in US youth with perinatal HIV: a longitudinal study. Kacanek D, Angelidou K, Williams PL, Chernoff M, Gadow KD, Nachman S; AIDS (London, England), 2015 Jun 19

Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. Weinberg A, Muresan P, Richardson KM, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ; PloS one, 2015

Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR; JAMA pediatrics, 2015 Mar

Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth. Curtis DJ, Muresan P, Nachman S, Fenton T, Richardson KM, Dominguez T, Flynn PM, Spector SA, Cunningham CK, Bloom A, Weinberg A; PloS one, 2015

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age. Nachman S, Alvero C, Acosta EP, Teppler H, Homony B, Graham B, Fenton T, Xu X, Rizk ML, Spector SA, Frenkel LM, Worrell C, Handelsman E, Wiznia A; Journal of the Pediatric Infectious Diseases Society, 2015 Dec

Heterogeneity of T Cell Responses to Pandemic pH1N1 Monovalent Vaccine in HIV-Infected Pregnant Women. Weinberg A, Muresan P, Richardson K, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ; AIDS research and human retroviruses, 2015 Nov

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. Naranbhai V,  Kim S, Fletcher H, Cotton MF, Violari A, Mitchell C, Nachman S, McSherry G, McShane H, Hill AV, Madhi SA; BMC medicine, 2014

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years. Nachman S, Zheng N, Acosta EP, Teppler H, Homony B, Graham B, Fenton T, Xu X, Wenning L, Spector SA, Frenkel LM, Alvero C, Worrell C, Handelsman E, Wiznia A; Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 2014 Feb

Participation and retention of youth with perinatal HIV infection in mental health research studies: the IMPAACT P1055 psychiatric comorbidity study. Williams PL, Chernoff M, Angelidou K, Brouwers P, Kacanek D, Deygoo NS, Nachman S, Gadow KD; Journal of acquired immune deficiency syndromes (1999), 2013 Jul 1

Requirements for the clinical evaluation of new anti-tuberculosis agents in children. Donald PR, Ahmed A, Burman WJ, Cotton MF, Graham SM, Mendel C, McIlleron H, Mac Kenzie WR, Nachman S, Schaaf HS, Starke JR, Wingfield C, Hesseling AC; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2013 Jun

Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women. Abzug MJ, Nachman SA, Muresan P, Handelsman E, Watts DH, Fenton T, Heckman B, Petzold E, Weinberg A, Levin MJ; Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 2013 May

High proportions of regulatory B and T cells are associated with decreased cellular responses to pH1N1 influenza vaccine in HIV-infected children and youth (IMPAACT P1088). Weinberg A, Muresan P, Fenton T, Richardson K, Dominguez T, Bloom A, Petzold E, Anthony P, Cunningham CK, Spector SA, Nachman S, Siberry GK, Handelsman E, Flynn PM; Human vaccines & immunotherapeutics, 2013 May

Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation. Syed SS, Balluz RS, Kabagambe EK, Meyer WA 3rd, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW; AIDS research and human retroviruses, 2013 Mar

Reply to Holm et al. Graham SM, Casenghi M, Jean-Philippe P, Hatherill M, Hesseling AC, Nachman S,  Starke JR, Swaminathan S, Cuevas LE; The Journal of infectious diseases, 2013 Mar 1

Central Nervous System Vasculopathy in HIV-Infected Children Enrolled in the Pediatric AIDS Clinical Trials Group 219/219C Study. Schieffelin JS, Williams PL, Djokic D, Anderson JP, Nachman S, Oleske JM, Seage GR 3rd, Van Dyke RB; Journal of the Pediatric Infectious Diseases Society, 2013 Mar

Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Siberry GK, Abzug MJ, Nachman S; Journal of the Pediatric Infectious Diseases Society, 2013 Dec

Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth. Pass RF, Nachman S, Flynn PM, Muresan P, Fenton T, Cunningham CK, Borkowsky W, McAuley JB, Spector SA, Petzold E, Levy W, Siberry GK, Handelsman E, Utech LJ, Weinberg A; Journal of the Pediatric Infectious Diseases Society, 2013 Dec

Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Siberry GK, Abzug MJ, Nachman S; The Pediatric infectious disease journal, 2013 Dec

Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, Mofenson LM, Nesheim S, National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics; The Pediatric infectious disease journal, 2013 Nov

Antibody persistence and immunologic memory after sequential pneumococcal conjugate and polysaccharide vaccination in HIV-infected children on highly active antiretroviral therapy. Abzug MJ, Song LY, Levin MJ, Nachman SA, Borkowsky W, Pelton SI; Vaccine, 2013 Oct 1

Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa. Beneri CA, Zeldow B, Nachman S, Van der Linde M, Pillay E, Dittmer S, Kim S, Jean-Philippe P, Coetzee J, Bobat R, Hawkins E, Violari A; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2013 Jan

Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy. Abzug MJ, Qin M, Levin MJ, Fenton T, Beeler JA, Bellini WJ, Audet S, Sowers SB, Borkowsky W, Nachman SA, Pelton SI, Rosenblatt HM; The Journal of infectious diseases, 2012 Aug 15

Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adults. Flynn PM, Nachman S, Muresan P, Fenton T, Spector SA, Cunningham CK, Pass R, Yogev R, Burchett S, Heckman B, Bloom A, Utech LJ, Anthony P, Petzold E, Levy W, Siberry GK, Ebiasah R, Miller J, Handelsman E, Weinberg A; The Journal of infectious diseases, 2012 Aug 1

Monitoring of HIV type 1 DNA load and drug resistance in peripheral blood mononuclear cells during suppressive antiretroviral therapy does not predict virologic failure. Beck IA, Jang M, McKernan-Mullin J, Bull M, Wagner T, Huang S, Song LY, Nachman S, Krogstad P, Eshleman SH, Wiznia A, Frenkel LM; AIDS research and human retroviruses, 2012 Aug

Nevirapine-based therapy after suppression: can we switch? Nachman S, McIntyre J; The Lancet infectious diseases, 2012 Jul

Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons. Gadow KD, Angelidou K, Chernoff M, Williams PL, Heston J, Hodge J, Nachman S; Journal of developmental and behavioral pediatrics: JDBP, 2012 Jul

Human immunodeficiency virus disease severity, psychiatric symptoms, and functional outcomes in perinatally infected youth. Nachman S, Chernoff M, Williams P, Hodge J, Heston J, Gadow KD; Archives of pediatrics & adolescent medicine, 2012 Jun 1

Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, Handelsman E, Hatherill M, Hesseling AC, Jean-Philippe P, Kampmann B, Kabra SK, Lienhardt C, Lighter-Fisher J, Madhi S, Makhene M, Marais BJ, McNeeley DF, Menzies H, Mitchell C, Modi S, Mofenson L, Musoke P, Nachman S, Powell C, Rigaud M, Rouzier V, Starke JR, Swaminathan S, Wingfield C; The Journal of infectious diseases, 2012 May 15

High prevalence of drug resistance amongst HIV-exposed and -infected children in a tuberculosis prevention trial. Hesseling AC, Kim S, Madhi S, Nachman S, Schaaf HS, Violari A, Victor TC, McSherry G, Mitchell C, Cotton MF; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2012 Feb

Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus. Lujan-Zilbermann J, Warshaw MG, Williams PL, Spector SA, Decker MD, Abzug MJ, Heckman B, Manzella A, Kabat B, Jean-Philippe P, Nachman S, Siberry GK; The Journal of pediatrics, 2012 Oct

Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected children. Siberry GK, Warshaw MG, Williams PL, Spector SA, Decker MD, Jean-Philippe P, Yogev R, Heckman BE, Manzella A, Roa J, Nachman S, Lujan-Zilbermann J; The Pediatric infectious disease journal, 2012 Jan

Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. Madhi SA, Nachman S,, Violari A, Kim S, Cotton MF, Bobat R, Jean-Philippe P, McSherry G, Mitchell C; The New England journal of medicine, 2011 Jul 7

Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer. Halasa N, Englund JA, Nachman S, Weinberg GA, Huber VC, Allison K, Dubovsky F, Yi T, McCullers JA, Flynn PM; Vaccine, 2011 May 31

Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. Hainline C, Taliep R, Sorour G, Nachman S, Rabie H, Dobbels E, van Rensburg AJ, Cornell M, Violari A, Madhi SA, Cotton MF; BMC research notes, 2011

Pharmacokinetics and distribution of linezolid in cerebrospinal fluid in children and adolescents. Yogev R, Damle B, Levy G, Nachman S; The Pediatric infectious disease journal, 2010 Sep

Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. Madhi SA, Adrian P, Cotton MF, McIntyre JA, Jean-Philippe P, Meadows S, Nachman S, Kayhty H, Klugman KP, Violari A; The Journal of infectious diseases, 2010 Aug 15

CYP2C19 genetic variants affect nelfinavir pharmacokinetics and virologic response in HIV-1-infected children receiving highly active antiretroviral therapy. Saitoh A, Capparelli E, Aweeka F, Sarles E, Singh KK, Kovacs A, Burchett SK, Wiznia A, Nachman S, Fenton T, Spector SA; Journal of acquired immune deficiency syndromes (1999), 2010 Jul

The link between religion and HAART adherence in pediatric HIV patients. Park J, Nachman S; AIDS care, 2010 May

Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents. Siberry GK, Williams PL, Lujan-Zilbermann J, Warshaw MG, Spector SA, Decker MD, Heckman BE, Demske EF, Read JS, Jean-Philippe P, Kabat W, Nachman S; The Pediatric infectious disease journal, 2010 May

Prevalence of pain and association with psychiatric symptom severity in perinatally HIV-infected children as compared to controls living in HIV-affected households. Serchuck LK, Williams PL, Nachman S, Gadow KD, Chernoff M, Schwartz L; AIDS care, 2010 May

Co-occuring psychiatric symptoms in children perinatally infected with HIV and peer comparison sample. Gadow KD, Chernoff M, Williams PL, Brouwers P, Morse E, Heston J, Hodge J, Di Poalo V, Deygoo NS, Nachman S; Journal of developmental and behavioral pediatrics: JDBP, 2010 Feb-Mar

Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children. Weinberg A, Song LY, Walker R, Allende M, Fenton T, Patterson-Bartlett J, Nachman S, Kemble G, Yi TT, Defechereux P, Wara D, Read JS, Levin M; Journal of acquired immune deficiency syndromes (1999), 2010 Oct

Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents. Williams PL, Leister E, Chernoff M, Nachman S, Morse E, Di Poalo V, Gadow KD; AIDS and behavior, 2010 Oct

T cell responses of HIV-infected children after administration of inactivated or live attenuated influenza vaccines. Weinberg A, Song LY, Fenton T, Nachman SA, Read JS, Patterson-Bartlett J, Levin MJ; AIDS research and human retroviruses, 2010 Jan

Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Abzug MJ, Warshaw M, Rosenblatt HM, Levin MJ, Nachman SA, Pelton SI, Borkowsky W, Fenton T; The Journal of infectious diseases, 2009 Sep 15

Virologic and immunologic correlates with the magnitude of antibody responses to the hepatitis A vaccine in HIV-infected children on highly active antiretroviral treatment. Weinberg A, Huang S, Fenton T, Patterson-Bartlett J, Gona P, Read JS, Dankner WM, Nachman S; Journal of acquired immune deficiency syndromes (1999), 2009 Sep 1

Mental health treatment patterns in perinatally HIV-infected youth and controls. Chernoff M, Nachman S, Williams P, Brouwers P, Heston J, Hodge J, Di Poalo V, Deygoo NS, Gadow KD; Pediatrics, 2009 Aug

To treat or not to treat? No longer a question. Beneri CA, Nachman S; Future microbiology, 2009 May

Lyme disease: new thoughts and directions. Nachman S; Pediatrics, 2009 May

Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Nachman SA, Chernoff M, Gona P, Van Dyke RB, Dankner WM, Seage GR 3rd, Oleske J, Williams PL; Archives of pediatrics & adolescent medicine, 2009 Feb

A window into a public program for prevention of mother to child transmission of HIV: evidence from a prospective clinical trial. Cotton M, Kim S, Rabie H, Coetzee J, Nachman S; Southern African journal of HIV medicine, 2009 Jan 1

Monosomy 1p36 uncovers a role for OX40 in survival of activated CD4+ T cells. Suhoski MM, Perez EE, Heltzer ML, Laney A, Shaffer LG, Saitta S, Nachman S, Spinner NB, June CH, Orange JS; Clinical immunology (Orlando, Fla.), 2008 Aug

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, Kemble G, Allende M, Hultquist M, Yi T, Nowak B, Weinberg A; Vaccine, 2008 Aug 5

Development of appropriate coronary heart disease risk prediction models in HIV-infected patients. Schambelan M, Wilson PW, Yarasheski KE, Cade WT, Davila-Roman VG, D'Agostino RB Sr, Helmy TA, Law M, Mondy KE, Nachman S, Peterson LR, Worm SW; Circulation, 2008 Jul 8

Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. Capparelli EV, Aweeka F, Hitti J, Stek A, Hu C, Burchett SK, Best B, Smith E, Read JS, Watts H, Nachman S, Thorpe EM Jr, Spector SA, Jimenez E, Shearer WT, Foca M, Mirochnick M; HIV medicine, 2008 Apr

Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S; The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2008 Feb

An evaluation of awareness: attitudes and beliefs of pregnant Nigerian women toward voluntary counseling and testing for HIV. Okonkwo KC, Reich K, Alabi AI, Umeike N, Nachman SA; AIDS patient care and STDs, 2007 Apr

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338). Fiscus SA, Kovacs A, Petch LA, Hu C, Wiznia AA, Mofenson LM, Yogev R, McIntosh K, Pelton SI, Napravnik S, Stanley K, Nachman SA; AIDS research and therapy, 2007

Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors. Reinis M, Weiser B, Kuiken C, Dong T, Lang D, Nachman S, Zhang Y, Rowland-Jones S, Burger H; AIDS research and human retroviruses, 2007 Feb

Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J; Pediatrics, 2007 Nov

CYP2B6 genetic variants are associated with nevirapine pharmacokinetics and clinical response in HIV-1-infected children. Saitoh A, Sarles E, Capparelli E, Aweeka F, Kovacs A, Burchett SK, Wiznia A, Nachman S, Fenton T, Spector SA; AIDS (London, England), 2007 Oct 18

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy. Ylitalo N, Brogly S, Hughes MD, Nachman S, Dankner W, Van Dyke R, Seage GR 3rd; Archives of pediatrics & adolescent medicine, 2006 Aug

Incidence of opportunistic and other infections in HIV-infected children in the HAART era. Gona P, Van Dyke RB, Williams PL, Dankner WM, Chernoff MC, Nachman SA, Seage GR 3rd; JAMA: the journal of the American Medical Association, 2006 Jul 19

Moving beyond the clinic: nutritional intervention in a human immunodeficiency virus-infected pregnant population. Seifert C, Reich K, Nachman S; Journal of the American Dietetic Association, 2006 Jul

Clinical and imaging study of human immunodeficiency virus-1-infected youth receiving highly active antiretroviral therapy: pilot study using magnetic resonance spectroscopy. Gabis L, Belman A, Huang W, Milazzo M, Nachman S; Journal of child neurology, 2006 Jun

A behavioral and cognitive profile of clinically stable HIV-infected children. Nozyce ML, Lee SS, Wiznia A, Nachman S, Mofenson LM, Smith ME, Yogev R, McIntosh K, Stanley K, Pelton S; Pediatrics, 2006 Mar